Anne-France Moreau has over a decade of experience counselling clients on corporate and general commercial law, with a particular focus on pharmaceutical, medical device, health care and cosmetics industries. Anne-France assists French and non-French groups in the preparation and negotiation of collaborations, licenses and distribution agreements. She has experience on a number of merger, acquisition and private equity transactions, including divestitures, financing rounds and joint ventures for French and non-French corporations. Further, Anne-France regularly handles digital health matters as well as regulatory issues.

Anne-France worked in a legal department of a French major leading pharmaceutical company, where she gained experience in pharmaceutical operations.

• Advised Egle Therapeutics in a corporate strategic research alliance with Takeda Pharmaceutical Company Limited to uncover novel tumor specific regulatory T-cell Targets and develop unique Anti-Suppressor-Based Immunotherapy
• Advised vaccines pioneers Themis on landmark sale to Merck
• Advised Innate Pharma in its multi-term collaboration with AstraZeneca

Show More

• Chambers Europe, France: Pharma/Life Sciences: Corporate, 2024
• The Best Lawyers in France, Healthcare Law, 2024
• The Legal 500 EMEA, Recommended, 2019-2024

Education
University of Paris I Panthéon-Sorbonne, Licence in Private Law, 2006
University of Paris I Panthéon-Sorbonne, Master’s 1, Business Law, 2007
University of Paris V Descartes, Master’s 2, Business and European Law, 2008

Admissions
Paris

Show More